Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation-Reference-Cited by-同舟云学术

Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation

Published:2017-07-28 Issue:7 Volume:12 Page:e0181357
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Paredes Roger,Tzou Philip L.,van Zyl Gert,Barrow Geoff,Camacho Ricardo,Carmona Sergio,Grant Philip M.,Gupta Ravindra K.,Hamers Raph L.,Harrigan P. Richard,Jordan Michael R.,Kantor Rami,Katzenstein David A.,Kuritzkes Daniel R.,Maldarelli Frank,Otelea Dan,Wallis Carole L.,Schapiro Jonathan M.,Shafer Robert W.^ORCID

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference76 articles.

1. European recommendations for the clinical use of HIV drug resistance testing: 2011 update;AM Vandamme;AIDS reviews,2011

2. Web resources for HIV type 1 genotypic-resistance test interpretation;TF Liu;Clinical infectious diseases: an official publication of the Infectious Diseases Society of America,2006

3. The HIVdb system for HIV-1 genotypic resistance interpretation;MW Tang;Intervirology,2012

4. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1;CJ Petropoulos;Antimicrobial agents and chemotherapy,2000

5. Monogram Biosciences. PhenoSense HIV Drug Resistance Assay Report Template (last accessed May 18, 2017). https://wwwmonogrambiocom/sites/monogrambio/files/imce/uploads/PS_report_new_Watermarkpdf. 2017.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incorporating temporal dynamics of mutations to enhance the prediction capability of antiretroviral therapy’s outcome for HIV-1;Bioinformatics;2024-05-22

2. Developing a next level integrated genomic surveillance: Advances in the molecular epidemiology of HIV in Germany;International Journal of Medical Microbiology;2024-03

3. Archived rilpivirine-associated resistance mutations among ART-naive and virologically suppressed people living with HIV-1 subtype C in Botswana: implications for cabotegravir/rilpivirine use;Journal of Antimicrobial Chemotherapy;2023-08-16

4. We should not stop considering HIV drug resistance testing at failure of first-line antiretroviral therapy;The Lancet HIV;2023-03

5. Highly Ambiguous HIV-1 Pol Positions Encoding Multiple Amino Acids Usually Result from Antiviral or Immune Selection Pressure;AIDS Research and Human Retroviruses;2023-03-01